Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM)
Clinical trial NCT02357147 · TERMINATED
Trial details
- NCT number
- NCT02357147
- Sponsor
- Morphotek
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-03
- Primary completion
- 2018-11-30
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.